TFG-001 / TreeFrog Therap - LARVOL DELTA

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease (Yahoo Finance) - "Rapid Dopamine Release: TFG-001 demonstrates dopamine release as early as 48 hours, versus ~28 days reported by benchmark cell therapies. Extensive Striatal Reinnervation: In vivo studies show that the graft successfully integrates and reinnervates target regions of the brain in the advanced translational Parkinson’s disease models."

Preclinical • Parkinson's Disease